WO2013011298A1 - Separation process - Google Patents

Separation process Download PDF

Info

Publication number
WO2013011298A1
WO2013011298A1 PCT/GB2012/051698 GB2012051698W WO2013011298A1 WO 2013011298 A1 WO2013011298 A1 WO 2013011298A1 GB 2012051698 W GB2012051698 W GB 2012051698W WO 2013011298 A1 WO2013011298 A1 WO 2013011298A1
Authority
WO
WIPO (PCT)
Prior art keywords
aliphatic ester
lactic acid
lactide
acid
mixture
Prior art date
Application number
PCT/GB2012/051698
Other languages
French (fr)
Inventor
Edward Leslie Marshall
Jade Jocelyn Afriye OSEI-TUTU
Stephen Alexander Calder SMITH
Original Assignee
Plaxica Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201112296A external-priority patent/GB201112296D0/en
Priority claimed from GB201112297A external-priority patent/GB201112297D0/en
Priority claimed from GB201210275A external-priority patent/GB201210275D0/en
Priority to CA2841930A priority Critical patent/CA2841930A1/en
Priority to JP2014519638A priority patent/JP2014522652A/en
Priority to AU2012285565A priority patent/AU2012285565B2/en
Application filed by Plaxica Limited filed Critical Plaxica Limited
Priority to EP12740196.6A priority patent/EP2732042A1/en
Priority to BR112014000848-5A priority patent/BR112014000848B1/en
Priority to KR1020147001960A priority patent/KR20140077877A/en
Priority to NZ619163A priority patent/NZ619163B2/en
Priority to CN201280034985.9A priority patent/CN103649324B/en
Priority to US14/232,365 priority patent/US9045782B2/en
Publication of WO2013011298A1 publication Critical patent/WO2013011298A1/en
Priority to ZA2013/09691A priority patent/ZA201309691B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/56Lactic acid

Definitions

  • the present invention relates to the production of single enantiomers of lactic acid, the cyclic dimer thereof (lactide) or lactate esters.
  • a separation process which includes the step of stereoselectively alcoholising a mixture of R,R- and S,S- lactide with an enzyme to produce single enantiomers of different lactic acid derivatives, aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid, which are separated from the enzyme with the enzyme being recycled, and which are separated from each other by fractional distillation.
  • Lactic acid (2-hydroxypropanoic acid) and its cyclic dimer lactide (3,6-dimethyl-l,4- dioxan-2,5-dione) are becoming increasingly important as building blocks for the chemical and pharmaceutical industries.
  • An example of this is in the use of lactide to manufacture polylactic acid; a polymer whose ability to be produced from a variety of renewable feedstocks and biodegradability makes it an attractive candidate to replace more conventional petrochemical polymers, such as polyethylene terephthalate, for example in the fabrication of food and beverage containers.
  • lactide is made from lactic acid which in turn is typically made by the bacterial fermentation of monosaccharides derived from crops such as maize and other natural products.
  • Lactic acid is chiral and can be made in two enantiomeric forms (respectively L-lactic acid (also referred to as S-lactic acid) on the one hand and D-lactic acid (R-lactic acid) on the other).
  • L-lactic acid also referred to as S-lactic acid
  • R-lactic acid D-lactic acid
  • Lactide are also chiral; lactide in particular exists in two enantiomeric forms (S,S-lactide and R,R- lactide) and a third diastereomeric R,S form sometimes also referred to as meso-lactide.
  • the conventional fermentation technologies referred to above principally generate L-lactic acid with little D-lactic acid being formed.
  • Polylactic acid is typically prepared in two steps in which lactic acid is first dehydrated to produce lactide and then the lactide is polymerised under carefully controlled conditions to ensure that long polymer chains are produced in preference to shorter oligomers. Since, as explained above, the most readily available source of lactic acid is L-lactic acid, the lactide employed commercially to date has been S,S-lactide and the polymer produced poly-L-lactic acid (PLLA) (also known as poly-S-lactic acid).
  • PLLA poly-L-lactic acid
  • PLLA poly-D-lactic acid
  • poly-R-lactic acid poly-R-lactic acid
  • the invention provides a reproducible and scaleable process which provides lactic acid derivatives in high enantiomeric purity and high yield.
  • the aliphatic ester, of lactic acid obtained from step (c) has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, yet more preferably at least 99%.
  • the aliphatic ester of lactyllactic acid obtained from step (c) has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, still more preferably at least 99%.
  • Step (a) of the process of the present invention comprises contacting the mixture of R,R- and S,S-lactide with an aliphatic alcohol and an enzyme capable of catalysing the desired transformation.
  • the mixture of R,R- and S,S- lactide may be racemic or scalemic. In one embodiment, the mixture of R,R- and S,S- lactide is racemic. In another embodiment, the mixture of R,R- and S,S- lactide is scalemic (i.e. non racemic).
  • the lactide used in this stage can in principle be derived from any source but one which is particularly suitable is racemic lactic acid produced by treating a monosaccharide (including glucose, fructose, xylose, and mixtures thereof) or a number of other carbohydrates (including formaldehyde, glyceraldehdye, dihydroxyacetone and glycerol) with a base in aqueous solution at elevated temperature.
  • a monosaccharide including glucose, fructose, xylose, and mixtures thereof
  • a number of other carbohydrates including formaldehyde, glyceraldehdye, dihydroxyacetone and glycerol
  • a base including formaldehyde, glyceraldehdye, dihydroxyacetone and glycerol
  • a base including formaldehyde, glyceraldehdye, dihydroxyacetone and glycerol
  • lactide is free or substantially free of the corresponding R,S diastereoisomer (meso lactide). If desired, R,S- lactide may be separated from R,R- and S,S-lactide, for example by routine methods well known in the art.
  • the aliphatic alcohol is a C ⁇ to Cg alcohol, preferably a C 2 to C alcohol, more preferably a C 3 to C 8 alcohol, most preferably a C 3 to C 4 alcohol.
  • the aliphatic alcohol is preferably an alkyl alcohol, more preferably a C 2 to C 8 alkyl alcohol, still more preferably a C 3 to C 8 alkyl alcohol, yet more preferably a C 3 -C 4 alkyl alcohol.
  • the alcohol may for example be ethanol, n-propanol, i-propanol, n-butanol, s-butanol, i-butanol or 2- ethylhexanol.
  • Examples of preferred alcohols include ethanol, n-propanol, i-propanol, and n-butanol. More preferably the alcohol is i-propanol, n-propanol or n-butanol. Still more preferably the alcohol is n-propanol or n-butanol. In one particularly preferred
  • the alkyl alcohol is n-butanol. In another embodiment the aliphatic alcohol is i-propanol. In another embodiment the aliphatic alcohol is n-propanol.
  • Step (a) can be carried out using the aliphatic alcohol as solvent in which case it is preferred that it is chosen so that the mixture of R,R- and S,S- lactide is completely or partially miscible therewith.
  • step (a) is carried out in the substantial absence of solvent other than aliphatic alcohol (i.e. in that case the alcohol, lactide and/or enzyme may contain some residual solvent, such as water).
  • other solvent may be present in addition to the aliphatic alcohol (e.g. a co- solvent) in step (a), for example a solvent/co-solvent that is miscible with the aliphatic alcohol.
  • solvent/co-solvent include unreactive oxygen-containing solvents for example dialkyl ethers (e.g. diethyl ether, dipropyl ether or MTBE), tetrahydrofuran, 1 ,4-dioxane, glycol ethers, polyalkylene glycol ethers and the like. Ketone solvents/co-solvents are particularly preferred.
  • Preferred ketone solvents include methyl ethyl ketone, methyl isobutyl ketone and, in particular, acetone. Such ketone solvents are particularly suitable for use in processes carried out on an industrial scale, where good solubility properties may be advantageous. Additional hydrocarbon solvents/co-solvents can also be advantageously added.
  • the aliphatic alcohol or the aliphatic alcohol/co-solvent mixture may contain some water. Typically, the aliphatic alcohol or the aliphatic alcohol/co-solvent mixture employed contains less than 1% preferably less than 0.5% by weight water to ensure that the enzyme performs optimally. In some preferred embodiments, molecular sieves are used in the process.
  • the process may be conducted using excess aliphatic alcohol together with additional solvent/co-solvent. It will be understood that the process may also be carried out using stoicheometric or even sub-stoicheometric quantities of aliphatic alcohol, and the "other" solvent may be the principal or only solvent.
  • the amount of aliphatic alcohol used in step (a) is such that the molar ratio of aliphatic alcohol to lactide is in the range 1 :1 to 10:1, preferably 2:1 to 5:1, more preferably 2:1 to 3:1.
  • the enzyme used in step (a) suitably comprises an esterase which is able to stereoselectively catalyse the reaction of aliphatic ester of lactyllactic acid with aliphatic alcohol to produce aliphatic ester of lactic acid.
  • the esterase is a lipase.
  • the enzyme e.g. the esterase, lipase
  • the enzyme is one which is either chemically or physically immobilised on a porous support for example a polymer resin bead or a silica, alumina or aluminosilicate bead.
  • Lipase B especially Candida antarctica Lipase B, a serine hydrolase with known enantiomeric selectivity towards the hydrolysis of secondary alcohol esters.
  • the Lipase B is most preferably chemically or physically bound to micro or nano beads made of a polymer resin for example a functionalised styrene/divinylbenzene copolymer or a polyacrylate resin, as is the case for example in the commercially available material Novozym 435 as used in the disclosure by Jeon et al.
  • the aliphatic lactate ester enantiomer that is preferentially produced is that derived from R-lactic acid and the remaining aliphatic lactyllactate ester enantiomer is that derived from S-lactic acid.
  • IMMCALB-T2-150 an immobilised lipase B from Candida antarctica covalently attached to dry acrylic beads, manufactured by Chiral vision
  • IMMCALBY-T2-150 a generic lipase B from Candida antarctica covalently attached to dry acrylic beads manufactured by Chiralvision
  • IMMCALB-Tl-350 a lipase B from Candida antarctica absorbed on dry polypropylene beads, manufactured by Chiralvision
  • cross-linked aggregate of lipase B from Candida antarctica manufactured by CLEA.
  • the enzyme may also be a recombinant Candida antarctica lipase B from Aspergillus oryzae, supplied by Sigma Aldrich (non-immobilised).
  • Step (a) is suitably carried out at a temperature in the range of from 15 to 140 °C in order to ensure that reaction rates are significant on the one hand and that the enzyme does not deteriorate with long term use on the other.
  • the temperature employed is in the range 25 to 80 °C most preferably 30 to 70 °C.
  • the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are respectively an aliphatic ester of R-lactic acid and an aliphatic ester of S,S- lactyllactic acid.
  • an enzyme such as a Candida antarctica lipase B (e.g. Novozym 435)
  • the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are respectively an aliphatic ester of R-lactic acid and an aliphatic ester of S,S- lactyllactic acid.
  • the enzyme is a Candida antarctica lipase B
  • the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are respectively an aliphatic ester of S-lactic acid and an aliphatic ester of R,R- lactyllactic acid.
  • Step (a) can be carried out on an industrial scale in a number of ways.
  • the reaction can be carried out batchwise in a single stirred or highly back-mixed tank after which the supported enzyme is separated in step (b), e.g. by filtration or the use of hydrocyclones, and the purified liquid fed to the kettle of the step (c) distillation column.
  • the residence time of the reactants and the enzyme in the stirred tank will typically be in the range up to 24 preferably up to 10, more preferably from 1 to 8 hours, and the amount of supported enzyme used will be in the range up to 10% preferably up to 5% by weight of the racemic lactide used.
  • the process may be operated as a continuous or semi-continuous process.
  • a mixture containing e.g. R,R- lactide and S,S-lactide, alkyl alcohol (e.g. n-butanol) and solvent/co-solvent (e.g. acetone) may be brought into contact with the enzyme (e.g. an immobilised enzyme such as Novozym 435) by passing the mixture through a packed bed of enzyme (e.g. present in a column).
  • the residency time is selected so as to ensure high conversion.
  • the packed bed is vertical, and the mixture is fed into the top of the column.
  • Ketone solvents/co-solvents are particularly preferred for use with such processes.
  • step (a) is carried out continuously in a tower reactor by for example trickling the liquid reactants down though a fixed or fluidised bed of the supported enzyme contained therein.
  • a product mixture comprising aliphatic ester of lactic acid, aliphatic ester of lactyllactic acid and optionally unreacted lactide, unreacted alcohol and solvent/co-solvent can then be recovered from the bottom of the tower and fed to stage (c).
  • the contact time of the reactants with the bed is typically in the range of up to 24 hours.
  • residency times contact time of the reactants with the bed
  • Arrangements of this type permit continuous or semi-continuous generation of product by flow operations.
  • the mixture containing aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid may be separated from the enzyme by, for example, by filtration of the enzyme, or by decanting or siphoning off the mixture prior to distillation.
  • the enzyme is re-used at least once, more preferably at least twice, still more preferably at least 5 times, yet more preferably at least 10 times, most preferably at least 20 times.
  • the process of the invention is a continuous or semi-continuous process which comprises contacting the mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. n-butanol) and an enzyme (e.g. Novozym 435), optionally in the presence of a solvent/co-solvent (e.g.
  • step (c) the aliphatic ester of lactic acid is separated from the aliphatic ester of lactyllactic acid by fractional distillation, preferably by distillation under reduced pressure.
  • lactic acid derivatives such as aliphatic esters of lactic acid and/or aliphatic esters of lactyllactic acid, may be susceptible to other undesired side-reactions on heating, for example lactic acid oligomers may be formed.
  • aliphatic ester of lactic acid e.g. i-propyl lactate, n-propyl lactate, n- butyl lactate
  • lactyllactic acid e.g. i-propyl
  • aliphatic ester of lactic acid e.g. i-propyl lactate, n-propyl lactate, n-butyl lactate
  • lactyllactic acid e.g.
  • aliphatic ester of lactic acid e.g. n-butyl lactate
  • lactyllactic acid e.g. n-butyl lactyllactate
  • aliphatic ester of lactic acid e.g. n-butyl lactate
  • lactyllactic acid e.g. n-butyl lactyllactate
  • fractional distillation at a pressure of from 1 ,000 Pa to 5,000 Pa and at a temperature of up to 180 °C, more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated by fractional distillation at a pressure of from 1,000 Pa to 5,000 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated from aliphatic ester of lactyllactic acid (e.g. n- butyl lactyllactate) by fractional distillation at a pressure of from 1,000 Pa to 5,000 Pa and at a temperature of from 75 °C to 110 °C.
  • lactyllactic acid e.g. n- butyl lactyllactate
  • aliphatic ester of lactic acid e.g. n-butyl lactate
  • lactyllactic acid e.g. n-butyl lactyllactate
  • fractional distillation at a pressure of from 2,000 Pa to 4,000 Pa and at a temperature of up to 180 °C, more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated by fractional distillation at a pressure of from 2000 Pa to 4000 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of from 2,000 Pa to 4,000 Pa and at a temperature of from 75 °C to 110 °C.
  • lactyllactic acid e.g. n-butyl lactyllactate
  • aliphatic ester of lactic acid e.g. i-propyl lactate, n-propyl lactate, n-butyl lactate
  • lactyllactic acid e.g. i-propyl lactyllactate, n-propyl lactyllactate, n-butyl lactyllactate
  • aliphatic ester of lactic acid e.g. i-propyl lactate, n-propyl lactate, n-butyl lactate
  • lactyllactic acid e.g. i-propyl lactyllactate, n-propyl lactyllactate, n-butyl lactyllactate
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated by fractional distillation at a pressure of from 2,500 Pa to 3,500 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated from aliphatic ester of lactyllactic acid (e.g. n- butyl lactyllactate) by fractional distillation at a pressure of from 2,500 Pa to 3,500 Pa and at a temperature of from 75°C to 110°C.
  • lactyllactic acid e.g. n- butyl lactyllactate
  • aliphatic ester of lactic acid e.g. n-butyl lactate
  • lactyllactic acid e.g. n-butyl lactyllactate
  • fractional distillation at a pressure of about 3,000 Pa and at a temperature of up to 180 °C, more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated by fractional distillation at a pressure of about 3,000 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C.
  • aliphatic ester of lactic acid e.g.
  • n-butyl lactate is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of about 3,000 Pa and at a temperature of from 75 °C to 110 °C.
  • the distillation column used may optionally contain packing in order to achieve improved separation efficiencies, for example Raschig rings or structured packing.
  • step (c) at least the lower boiling aliphatic lactate ester fraction is removed overhead for further use or treatment thereby indirectly effecting separation of the two lactic acid enantiomers.
  • the aliphatic ester of lactic acid is removed overhead by distillation, and the distillation residue comprises the aliphatic ester of lactyllactic acid, which may be removed via a side stream.
  • both the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are removed overhead by distillation (e.g. they are collected as separate overhead product streams, for example at different temperatures and/or pressures).
  • the distillation column also known as a fractionation column used for step (c) must have the necessary number of theoretical plates to perform its function (i.e. to enable separation of aliphatic ester of lactic acid from aliphatic ester of lactyllactic acid).
  • the reaction will likely have gone to completion and the residuum in the boiler of the distillation column will generally comprise an aliphatic lactyllactate ester fraction which can then be removed by a side stream for its own further treatment and use.
  • step (c) may also operate continuously with recycle to ensure that at steady state all of the R,R- or S,S-lactide is converted quantitatively (as the case may be) to aliphatic ester of S-lactic acid or aliphatic ester of R-lactic acid, and that the corresponding aliphatic ester of lactyllactic acid is recovered in single enantiomeric form.
  • the distillation can be effected in either a single column or a train of columns arranged in series.
  • the distillation column(s) used in step (c) are operated at a pressure of less than 5,000 Pa.
  • the single enantiomer of the aliphatic lactate ester recovered in step (c) can be converted to either the corresponding lactic acid enantiomer or to the corresponding lactide enantiomer.
  • the aliphatic alcohol is released and can be separated and recycled to step (a).
  • the supported enzyme used is Novozym 435
  • the alcohol is n-butanol and the solvent is acetone
  • the R-n-butyl lactate so generated can be converted to R-lactic acid or R,R- lactide. If R,R- lactide is produced it can then be polymerised to produce optically pure PDLA.
  • the single enantiomer of the aliphatic lactyllactate ester if recovered in pure form in step (c) can be converted back to either the corresponding lactic acid or lactide enantiomer so that for example in the case that the aliphatic ester of lactyllactic acid is S,S- n-butyl lactyllactate, it can be hydrolysed to S-lactic acid or converted into S,S- lactide, which can then be polymerised to produce optically pure PLLA.
  • a process for producing S-lactic acid characterised by the steps of: contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a Q to C 8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is
  • the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid.
  • the S-lactic acid produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
  • a process for producing R,R-lactide characterised by the steps of contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a Ci to C 8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid
  • an aliphatic alcohol e.g. a Ci to C 8 alkyl alcohol
  • the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid.
  • the R,R-lactide produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
  • a process for producing R-lactic acid characterised by the steps of: contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a Q to C 8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic alcohol (e.g. a Q to
  • the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid.
  • the R-lactic acid produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
  • a process for producing S,S-lactide characterised by the steps of contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a C ⁇ to C 8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer;
  • an aliphatic alcohol e.g. a C ⁇ to C 8 alkyl alcohol
  • the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid.
  • the S,S-lactide produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
  • Conversion of the mixture of R- and S- lactic acid into a mixture of R,R and S,S- lactide may result in formation of R,S-lactide, as well as R,R- and S,S-lactide. If desired, R,S- lactide may be separated from R,R- and S,S-lactide by routine methods well known in the art.
  • the R,R- and S,S-lactides produced in respectively the second or fourth further embodiments set out above are separately polymerised to produce substantially optically pure PDLA or PLLA.
  • PDLA and PLLA can be combined in varying proportions, for example using melt blending, to produce a range of stereocomplex polylactic acid formulations having an associated range of improved optical and form stability properties relative to either PLLA or PDLA alone. Whilst the relative proportions of these two polymers can vary widely it is preferred that the PLLA content of these formulations lie in the range 40 to 60% based on the total weight of PLLA and PDLA.
  • the stereocomplex polymers so produced can be used in a wide range of applications, including a wider scope of durable uses previously not possible with PLLA.
  • a portion of the residue (100 ml) was transferred to a round-bottomed flask equipped with a distillation column packed with Raschig rings, a still-head and condenser. Distillation was then carried out at 30 mbar, the vacuum being maintained by a Vacuubrand CVC 2000 controller.
  • Fractions were collected as summarised in the Table below.
  • Fractions 4 and 5 contained mixtures of (R)-n-butyl lactate and (S,S)-n-butyl lactyllactate, highlighting the difficulty in achieving separation of these components.
  • Fractions 2 and 3 contained (R)-n- butyl lactate but no n-butyl lactylactate.
  • Fraction 3 contained (R)-n-butyl lactate in > 98% ee. The results demonstrate that separation of alkyl lactate from alkyl lactylactate by distillation is possible without significant loss of enantiomeric purity.
  • a 1 litre 3-necked glass flask was fitted with a magnetic stirrer bar and an insulated 20-plate Oldershaw column surmounted by a Perkin vacuum still head with 250 ml receiver.
  • a feed point approximately half-way up the column allowed feedstock to be charged via a peristaltic pump using PharMed ® BPT peristaltic tubing.
  • the flask was heated using an oil bath and vacuum was applied via a Teflon diaphragm pump, with a solid C0 2 cooled trap.
  • the feedstock for this distillation consisted of acetone (49% wt); (R)-n-butyl lactate (21% wt); butanol (7% wt); (R,R)-n-butyl lactyllactate (3% wt) and (S,S)-n-butyl lactyllactate (19% wt).
  • the remaining components included trace quantities of (S)-n- butyl lactate and both (S,S)- and (R,R)-lactides.
  • the composition of the resulting concentrated product (340.11 g) was: acetone (4.5%); (R)-n-butyl lactate (44.3%); n- butanol (4.7%); (R,R)-n-butyl lactyllactate (5.9%), (S,S)-n-butyl lactyllactate (39.0%) and (S)-n-butyl lactate (0.7%) with the remainder being (S,S)- and (R,R)-lactides.
  • composition of the volatile products collected in the cold trap (59.7 g) was: acetone (89%) and butanol (10%) with the remaining 1% being n-butyl lactate.
  • a continuous distillation set up was constructed comprising a 250 ml Hastelloy reboiler (with sightglass), a trace-heated 20-plate Oldershaw column surmounted by a Perkin vacuum still head with 250 ml receiver. There was a feed point approximately half-way up the column allowing feedstock to be charged via a peristaltic pump using PharMed ® BPT peristaltic tubing. The temperature of the reboiler and column heat tracing were electrically controlled. Vacuum was applied via a Teflon diaphragm pump, with a solid C0 2 cooled trap.
  • the feedstock for this distillation (1050.0 g) consisted of: acetone (49% wt); (R)- n-butyl lactate (21% wt); butanol (7% wt); (R,R)-n-butyl lactyllactate (3% wt) and (S,S)- n-butyl lactyllactate (19% wt) with traces of (S)-n-butyl lactate and both (S,S)- and (R,R)- lactides.
  • BuLa butyl lactate
  • BuLaLa butyl lactyl lactate
  • a continuous distillation apparatus comprising a 250 ml Hastelloy reboiler with sightglass fitted with a heated 20-plate Oldershaw column surmounted by a Perkin vacuum still head with 250 ml receiver. There was a feed point approximately half-way up the column allowing feedstock to be charged via a peristaltic pump using PharMed ® BPT peristaltic tubing. The temperature of the reboiler and column heat tracing were electrically controlled. Vacuum was applied via a Teflon diaphragm pump, with a solid C0 2 cooled trap.
  • the feedstock for this distillation (740.5 g) consisted of: acetone ( ⁇ 0.5%); (R)-n- butyl lactate (46%); butanol (3%); (R,R)-n-butyl lactyllactate (6%) and (S,S)-n-butyl lactyllactate (44%) with trace quantities ( ⁇ 0.5%) of (S)-n-butyl lactate and both (S,S)- and (R,R)-lactides.
  • BuLa butyl lactate
  • BuLaLa butyl lactyl lactate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

A process for treating a mixture of R,R- and S,S- lactide is provided. The process involves contacting the mixture with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture from the enzyme, and recycling the enzyme to the process; and separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation. Also provided are processes for the production of S-lactic acid, S,S- lactide, poly-S-lactic acid, R-lactic acid, R,R-lactide, poly-R-lactic acid and stereocomplex polylactic acid.

Description

SEPARATION PROCESS
The present invention relates to the production of single enantiomers of lactic acid, the cyclic dimer thereof (lactide) or lactate esters. In particular, it relates to a separation process which includes the step of stereoselectively alcoholising a mixture of R,R- and S,S- lactide with an enzyme to produce single enantiomers of different lactic acid derivatives, aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid, which are separated from the enzyme with the enzyme being recycled, and which are separated from each other by fractional distillation.
Lactic acid (2-hydroxypropanoic acid) and its cyclic dimer lactide (3,6-dimethyl-l,4- dioxan-2,5-dione) are becoming increasingly important as building blocks for the chemical and pharmaceutical industries. An example of this is in the use of lactide to manufacture polylactic acid; a polymer whose ability to be produced from a variety of renewable feedstocks and biodegradability makes it an attractive candidate to replace more conventional petrochemical polymers, such as polyethylene terephthalate, for example in the fabrication of food and beverage containers. Today, lactide is made from lactic acid which in turn is typically made by the bacterial fermentation of monosaccharides derived from crops such as maize and other natural products. Lactic acid is chiral and can be made in two enantiomeric forms (respectively L-lactic acid (also referred to as S-lactic acid) on the one hand and D-lactic acid (R-lactic acid) on the other). Derivatives such as lactide are also chiral; lactide in particular exists in two enantiomeric forms (S,S-lactide and R,R- lactide) and a third diastereomeric R,S form sometimes also referred to as meso-lactide. The conventional fermentation technologies referred to above principally generate L-lactic acid with little D-lactic acid being formed. Although these technologies can be modified using different, often genetically engineered, bacteria to produce D-lactic acid in a similarly selective manner, to date the modified bacteria and the associated processes are expensive and difficult to use reliably on a large industrial scale. This is evidenced in the comparatively higher price and limited availability of D-lactic acid.
Polylactic acid is typically prepared in two steps in which lactic acid is first dehydrated to produce lactide and then the lactide is polymerised under carefully controlled conditions to ensure that long polymer chains are produced in preference to shorter oligomers. Since, as explained above, the most readily available source of lactic acid is L-lactic acid, the lactide employed commercially to date has been S,S-lactide and the polymer produced poly-L-lactic acid (PLLA) (also known as poly-S-lactic acid).
However the physical properties of PLLA are limited relative to conventional polymers (as are those of the corresponding poly-D-lactic acid (PDLA), also known as poly-R-lactic acid) which to date has limited its utility.
It has been found that these deficiencies can be overcome by using mixtures of PLLA and PDLA which are prepared by, for example, melt blending. It is believed that in these so-called 'stereocomplex' polymer mixtures close packing of the PLLA and PDLA chains occasioned by their differing chirality improves polymer crystallinity which leads to improvements in the properties referred to above. This permits the use of stereocomplex PLA for a much wider range of consumer durable applications, making it a viable alternative to traditional commodity polymers such as polyethylene terephthalate, polypropylene and polystyrene. This approach however requires access to large quantities of PDLA and therefore ultimately to large quantities of D-lactic acid.
In addition to the use of fermentation methods, it is known to produce lactic acid by a conventional chemical transformation. For example, the prior art teaches it can be made by treating monosaccharides derived from a wide range of biological material with aqueous strong base. Such processes however are not stereoselective and generate a racemic mixture of the two enantiomers in approximately equal amounts. They are therefore attractive as a way of making the precursors of stereocomplex polylactic acid. There is a problem however with using racemic lactic acid to make polylactic acid in that the resulting polymer is amorphous and therefore also has poor processing properties. It is therefore necessary to separate the enantiomers present in the racemic lactic acid or those in the corresponding racemic lactide so that the enantiomers of the latter can be
polymerised separately and the two chiral polymers mixed only at the final formulation stage.
Separating a racemic mixture into its constituent enantiomers is in general terms a well-known endeavour and strategies adopted have included fractional crystallisation and chromatography. However neither of these methodologies is easy to operate on a large scale, especially in commodity scale polymer manufacturing where throughputs are high and operating costs need to be carefully controlled. What is needed therefore is a simple chemical engineering solution which can be easily and reproducibly operated at scale. Jeon et al in Tetrahedron Letters 47 (2006) 6517-6520 disclose the laboratory observation that rac-lactide can be alcoholised with various alcohols in the presence of a solvent and the supported lipase enzyme Novozym 435 to produce a product comprising a mixture of the corresponding R-alkyl lactate and the S,S-alkyl lactyllactate. However, this reference goes no further than describing the chemistry.
We have now found a flexible and efficient process that permits the production of aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid on industrial scale in good yield. According to the present invention there is therefore provided a process for treating a mixture of R,R- and S,S- lactide characterised by the steps of:
(a) contacting the mixture of R,R- and S,S- lactide with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer;
(b) separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; and
(c) separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation.
The invention provides a reproducible and scaleable process which provides lactic acid derivatives in high enantiomeric purity and high yield. Preferably, the aliphatic ester, of lactic acid obtained from step (c) has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, yet more preferably at least 99%. Preferably, the aliphatic ester of lactyllactic acid obtained from step (c) has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, still more preferably at least 99%.
Step (a) of the process of the present invention comprises contacting the mixture of R,R- and S,S-lactide with an aliphatic alcohol and an enzyme capable of catalysing the desired transformation. The mixture of R,R- and S,S- lactide may be racemic or scalemic. In one embodiment, the mixture of R,R- and S,S- lactide is racemic. In another embodiment, the mixture of R,R- and S,S- lactide is scalemic (i.e. non racemic).
The lactide used in this stage can in principle be derived from any source but one which is particularly suitable is racemic lactic acid produced by treating a monosaccharide (including glucose, fructose, xylose, and mixtures thereof) or a number of other carbohydrates (including formaldehyde, glyceraldehdye, dihydroxyacetone and glycerol) with a base in aqueous solution at elevated temperature. Especially preferred is the use of a Group IA, Group IIA or quaternary ammonium bases as described for example in GB2484674, the prior art discussed therein, and in US 7829740. Typically the racemic lactic acid produced in these processes can be converted into racemic lactide by
dehydration processes well-known in the art. It is preferred that the lactide is free or substantially free of the corresponding R,S diastereoisomer (meso lactide). If desired, R,S- lactide may be separated from R,R- and S,S-lactide, for example by routine methods well known in the art.
Suitably the aliphatic alcohol is a C\ to Cg alcohol, preferably a C2 to C alcohol, more preferably a C3 to C8 alcohol, most preferably a C3 to C4 alcohol. The aliphatic alcohol is preferably an alkyl alcohol, more preferably a C2 to C8 alkyl alcohol, still more preferably a C3 to C8 alkyl alcohol, yet more preferably a C3-C4 alkyl alcohol. The alcohol may for example be ethanol, n-propanol, i-propanol, n-butanol, s-butanol, i-butanol or 2- ethylhexanol. Examples of preferred alcohols include ethanol, n-propanol, i-propanol, and n-butanol. More preferably the alcohol is i-propanol, n-propanol or n-butanol. Still more preferably the alcohol is n-propanol or n-butanol. In one particularly preferred
embodiment the alkyl alcohol is n-butanol. In another embodiment the aliphatic alcohol is i-propanol. In another embodiment the aliphatic alcohol is n-propanol.
Step (a) can be carried out using the aliphatic alcohol as solvent in which case it is preferred that it is chosen so that the mixture of R,R- and S,S- lactide is completely or partially miscible therewith. Thus, in one embodiment step (a) is carried out in the substantial absence of solvent other than aliphatic alcohol (i.e. in that case the alcohol, lactide and/or enzyme may contain some residual solvent, such as water). In other embodiments, other solvent may be present in addition to the aliphatic alcohol (e.g. a co- solvent) in step (a), for example a solvent/co-solvent that is miscible with the aliphatic alcohol. If the mixture of R,R- and S,S- lactide is immiscible or has only low miscibility with the alcohol it is possible and in many cases preferred to employ a solvent/co-solvent with which both components are miscible. Use of a solvent/co-solvent may also lead to further processing advantages in step (c). Typical preferred examples of solvent/co-solvent include unreactive oxygen-containing solvents for example dialkyl ethers (e.g. diethyl ether, dipropyl ether or MTBE), tetrahydrofuran, 1 ,4-dioxane, glycol ethers, polyalkylene glycol ethers and the like. Ketone solvents/co-solvents are particularly preferred.
Preferred ketone solvents include methyl ethyl ketone, methyl isobutyl ketone and, in particular, acetone. Such ketone solvents are particularly suitable for use in processes carried out on an industrial scale, where good solubility properties may be advantageous. Additional hydrocarbon solvents/co-solvents can also be advantageously added. The aliphatic alcohol or the aliphatic alcohol/co-solvent mixture may contain some water. Typically, the aliphatic alcohol or the aliphatic alcohol/co-solvent mixture employed contains less than 1% preferably less than 0.5% by weight water to ensure that the enzyme performs optimally. In some preferred embodiments, molecular sieves are used in the process.
The process may be conducted using excess aliphatic alcohol together with additional solvent/co-solvent. It will be understood that the process may also be carried out using stoicheometric or even sub-stoicheometric quantities of aliphatic alcohol, and the "other" solvent may be the principal or only solvent. Typically the amount of aliphatic alcohol used in step (a) is such that the molar ratio of aliphatic alcohol to lactide is in the range 1 :1 to 10:1, preferably 2:1 to 5:1, more preferably 2:1 to 3:1.
The enzyme used in step (a) suitably comprises an esterase which is able to stereoselectively catalyse the reaction of aliphatic ester of lactyllactic acid with aliphatic alcohol to produce aliphatic ester of lactic acid. More preferably, the esterase is a lipase. Preferably the enzyme (e.g. the esterase, lipase) is one which is either chemically or physically immobilised on a porous support for example a polymer resin bead or a silica, alumina or aluminosilicate bead. One particularly preferred example is Lipase B, especially Candida antarctica Lipase B, a serine hydrolase with known enantiomeric selectivity towards the hydrolysis of secondary alcohol esters. In this aspect of the invention, the Lipase B is most preferably chemically or physically bound to micro or nano beads made of a polymer resin for example a functionalised styrene/divinylbenzene copolymer or a polyacrylate resin, as is the case for example in the commercially available material Novozym 435 as used in the disclosure by Jeon et al. As Jeon demonstrates, when this particular supported enzyme is used the aliphatic lactate ester enantiomer that is preferentially produced is that derived from R-lactic acid and the remaining aliphatic lactyllactate ester enantiomer is that derived from S-lactic acid. Other preferred enzymes include IMMCALB-T2-150, an immobilised lipase B from Candida antarctica covalently attached to dry acrylic beads, manufactured by Chiral vision; IMMCALBY-T2-150, a generic lipase B from Candida antarctica covalently attached to dry acrylic beads manufactured by Chiralvision; IMMCALB-Tl-350, a lipase B from Candida antarctica absorbed on dry polypropylene beads, manufactured by Chiralvision; and cross-linked aggregate of lipase B from Candida antarctica, manufactured by CLEA. The enzyme may also be a recombinant Candida antarctica lipase B from Aspergillus oryzae, supplied by Sigma Aldrich (non-immobilised).
Step (a) is suitably carried out at a temperature in the range of from 15 to 140 °C in order to ensure that reaction rates are significant on the one hand and that the enzyme does not deteriorate with long term use on the other. Preferably the temperature employed is in the range 25 to 80 °C most preferably 30 to 70 °C.
Typically, when an enzyme such as a Candida antarctica lipase B (e.g. Novozym 435) is used, the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are respectively an aliphatic ester of R-lactic acid and an aliphatic ester of S,S- lactyllactic acid. By varying the reaction conditions it may be possible to alter the enzyme selectivity. Thus in another, less preferred, embodiment the enzyme is a Candida antarctica lipase B, and the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are respectively an aliphatic ester of S-lactic acid and an aliphatic ester of R,R- lactyllactic acid.
Step (a) can be carried out on an industrial scale in a number of ways. For example, if a supported enzyme is used the reaction can be carried out batchwise in a single stirred or highly back-mixed tank after which the supported enzyme is separated in step (b), e.g. by filtration or the use of hydrocyclones, and the purified liquid fed to the kettle of the step (c) distillation column. In such a case the residence time of the reactants and the enzyme in the stirred tank will typically be in the range up to 24 preferably up to 10, more preferably from 1 to 8 hours, and the amount of supported enzyme used will be in the range up to 10% preferably up to 5% by weight of the racemic lactide used.
In an alternative preferred embodiment, the process may be operated as a continuous or semi-continuous process. For example, a mixture containing e.g. R,R- lactide and S,S-lactide, alkyl alcohol (e.g. n-butanol) and solvent/co-solvent (e.g. acetone) may be brought into contact with the enzyme (e.g. an immobilised enzyme such as Novozym 435) by passing the mixture through a packed bed of enzyme (e.g. present in a column). In such flow processes, the residency time is selected so as to ensure high conversion. In a particularly preferred embodiment, the packed bed is vertical, and the mixture is fed into the top of the column. Ketone solvents/co-solvents are particularly preferred for use with such processes.
In one preferred embodiment, step (a) is carried out continuously in a tower reactor by for example trickling the liquid reactants down though a fixed or fluidised bed of the supported enzyme contained therein. A product mixture comprising aliphatic ester of lactic acid, aliphatic ester of lactyllactic acid and optionally unreacted lactide, unreacted alcohol and solvent/co-solvent can then be recovered from the bottom of the tower and fed to stage (c). In this arrangement, the contact time of the reactants with the bed is typically in the range of up to 24 hours. Preferably residency times (contact time of the reactants with the bed) are in the range of from 10 minutes to 4 hours, more preferably from 10 minutes to 2 hours. Arrangements of this type permit continuous or semi-continuous generation of product by flow operations.
Where the process is operated in a batch-type reactor, the mixture containing aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid may be separated from the enzyme by, for example, by filtration of the enzyme, or by decanting or siphoning off the mixture prior to distillation. Preferably, in the case of a batch-type process, the enzyme is re-used at least once, more preferably at least twice, still more preferably at least 5 times, yet more preferably at least 10 times, most preferably at least 20 times.
In the case of a process where R,R-lactide, S,S-lactide and alcohol are passed through a packed bed of enzyme (i.e. a continuous or semi-continuous flow process), product and enzyme are continually being separated from one another and the enzyme is continually being recycled. Accordingly, in one preferred embodiment, the process of the invention is a continuous or semi-continuous process which comprises contacting the mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. n-butanol) and an enzyme (e.g. Novozym 435), optionally in the presence of a solvent/co-solvent (e.g. acetone) to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer, by passing a solution containing R,R- and S,S- lactide, aliphatic alcohol and optionally solvent/co-solvent through a packed bed of immobilised enzyme; and separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation.
In step (c), the aliphatic ester of lactic acid is separated from the aliphatic ester of lactyllactic acid by fractional distillation, preferably by distillation under reduced pressure.
It has been found that the aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid can be efficiently separated at elevated temperature by fractional distillation without either of the two products undergoing racemisation during this stage. This we believe is surprising given the known tendency of lactic acid derivatives to undergo facile epimerisation. For example Shuklov et al in Tetrahedron Letters 52 (2011) 1027-30 disclose that lactide isomers can undergo reversible epimerisation to generate mixtures of the two enantiomeric lactides and the meso-form even at room temperature. Nishida et al (Polymer Degradation and Stability, 92 (2007) 552-559) have also reported on the racemisation of S,S-lactide at elevated temperatures. In addition, lactic acid derivatives, such as aliphatic esters of lactic acid and/or aliphatic esters of lactyllactic acid, may be susceptible to other undesired side-reactions on heating, for example lactic acid oligomers may be formed.
Once these two components (i.e. aliphatic ester of lactic acid and aliphatic ester of lactyllactic acid) are separated, the fact that they are associated with different enantiomers of lactic acid means that by subsequent chemical transformations they can each be converted to optically pure R,R- and S,S-lactide, or if desired optically pure R- and S-lactic acid which can be used in other non-polymer producing applications.
Preferably, aliphatic ester of lactic acid (e.g. i-propyl lactate, n-propyl lactate, n- butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. i-propyl
lactyllactate, n-propyl lactyllactate, n-butyl lactyllactate) by fractional distillation at a pressure of from 100 Pa (1 mbar) to 10,000 Pa (100 mbar), more preferably 1,000 Pa (10 mbar) to 5,000 Pa (50 mbar), still more preferably at a pressure of from 2,000 Pa (20 mbar) to 4,000 Pa (40 mbar), yet more preferably at a pressure of from 2,500 Pa (25 mbar) to 3,500 Pa (35 mbar), most preferably at a pressure of about 3,000 Pa (30 mbar).
Preferably, aliphatic ester of lactic acid (e.g. i-propyl lactate, n-propyl lactate, n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. i-propyl lactyllactate, n- propyl lactyllactate, n-butyl lactyllactate) by fractional distillation at a temperature of up to 180 °C (for example at a temperature of from 40 °C to 170 °C), more preferably up to 160 , still more preferably up to 140 °C, yet more preferably up to 120 °C, more preferably at a temperature from 50 °C to 120 °C, still more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100°C. In one embodiment, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a
temperature of from 75 °C to 110 °C.
In certain embodiments, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of from 1 ,000 Pa to 5,000 Pa and at a temperature of up to 180 °C, more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C. More preferably, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated by fractional distillation at a pressure of from 1,000 Pa to 5,000 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C. In one embodiment, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n- butyl lactyllactate) by fractional distillation at a pressure of from 1,000 Pa to 5,000 Pa and at a temperature of from 75 °C to 110 °C.
In certain embodiments, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of from 2,000 Pa to 4,000 Pa and at a temperature of up to 180 °C, more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C. More preferably, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated by fractional distillation at a pressure of from 2000 Pa to 4000 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C. In one embodiment, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of from 2,000 Pa to 4,000 Pa and at a temperature of from 75 °C to 110 °C.
In certain embodiments, aliphatic ester of lactic acid (e.g. i-propyl lactate, n-propyl lactate, n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. i-propyl lactyllactate, n-propyl lactyllactate, n-butyl lactyllactate) by fractional distillation at a pressure of from 2,500 Pa to 3,500 Pa and at a temperature of up to 180 °C , more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C. More preferably, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated by fractional distillation at a pressure of from 2,500 Pa to 3,500 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C. In one embodiment, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n- butyl lactyllactate) by fractional distillation at a pressure of from 2,500 Pa to 3,500 Pa and at a temperature of from 75°C to 110°C.
In certain embodiments, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of about 3,000 Pa and at a temperature of up to 180 °C, more preferably up to 160 °C, still more preferably up to 140 °C, yet more preferably up to 120 °C. More preferably, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated by fractional distillation at a pressure of about 3,000 Pa and at a temperature of from 50 °C to 120 °C, more preferably from 50 °C to 110 °C, yet more preferably from 52 °C to 110 °C, more preferably from 52 °C to 105 °C, still more preferably from 75 °C to 105 °C, yet more preferably from 90 °C to 105 °C, more preferably from 95 °C to 102 °C, most preferably at a temperature of about 100 °C. In one embodiment, aliphatic ester of lactic acid (e.g. n-butyl lactate) is separated from aliphatic ester of lactyllactic acid (e.g. n-butyl lactyllactate) by fractional distillation at a pressure of about 3,000 Pa and at a temperature of from 75 °C to 110 °C. The distillation column used may optionally contain packing in order to achieve improved separation efficiencies, for example Raschig rings or structured packing.
In step (c), at least the lower boiling aliphatic lactate ester fraction is removed overhead for further use or treatment thereby indirectly effecting separation of the two lactic acid enantiomers. In a preferred embodiment, the aliphatic ester of lactic acid is removed overhead by distillation, and the distillation residue comprises the aliphatic ester of lactyllactic acid, which may be removed via a side stream. In an alternative
embodiment, both the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are removed overhead by distillation (e.g. they are collected as separate overhead product streams, for example at different temperatures and/or pressures).
The distillation column (also known as a fractionation column) used for step (c) must have the necessary number of theoretical plates to perform its function (i.e. to enable separation of aliphatic ester of lactic acid from aliphatic ester of lactyllactic acid). In the case where the reaction is carried out batchwise the reaction will likely have gone to completion and the residuum in the boiler of the distillation column will generally comprise an aliphatic lactyllactate ester fraction which can then be removed by a side stream for its own further treatment and use. If steps (a) and (b) are operated continuously then the distillation column in step (c) may also operate continuously with recycle to ensure that at steady state all of the R,R- or S,S-lactide is converted quantitatively (as the case may be) to aliphatic ester of S-lactic acid or aliphatic ester of R-lactic acid, and that the corresponding aliphatic ester of lactyllactic acid is recovered in single enantiomeric form. In this continuously operated case the distillation can be effected in either a single column or a train of columns arranged in series. Typically the distillation column(s) used in step (c) are operated at a pressure of less than 5,000 Pa.
In an embodiment of the present invention the single enantiomer of the aliphatic lactate ester recovered in step (c) can be converted to either the corresponding lactic acid enantiomer or to the corresponding lactide enantiomer. In both cases, the aliphatic alcohol is released and can be separated and recycled to step (a). For example, in the case where the supported enzyme used is Novozym 435, the alcohol is n-butanol and the solvent is acetone, the R-n-butyl lactate so generated can be converted to R-lactic acid or R,R- lactide. If R,R- lactide is produced it can then be polymerised to produce optically pure PDLA. Likewise, the single enantiomer of the aliphatic lactyllactate ester if recovered in pure form in step (c) can be converted back to either the corresponding lactic acid or lactide enantiomer so that for example in the case that the aliphatic ester of lactyllactic acid is S,S- n-butyl lactyllactate, it can be hydrolysed to S-lactic acid or converted into S,S- lactide, which can then be polymerised to produce optically pure PLLA.
Thus, according to a first further embodiment of the present invention there is provided a process for producing S-lactic acid characterised by the steps of: contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a Q to C8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of S,S-lactyllactic acid, hydrolysing the aliphatic ester of S,S- lactyllactic acid to produce S-lactic acid or, where the aliphatic ester of lactic acid is an aliphatic ester of S-lactic acid, hydrolysing the aliphatic ester of S-lactic acid to produce S-lactic acid. Preferably, the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid. The S-lactic acid produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
Alternatively, according to a second further embodiment of the present invention there is provided a process for producing R,R-lactide characterised by the steps of contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a Ci to C8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid
corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of R,R-lactyllactic acid, converting the aliphatic ester of R,R-lactyllactic acid to R,R-lactide or, where the aliphatic ester of lactic acid is an aliphatic ester of R-lactic acid, converting the aliphatic ester of R-lactic acid to R,R-lactide. Preferably, the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid. The R,R-lactide produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
Alternatively in a third further embodiment of the present invention there is provided a process for producing R-lactic acid characterised by the steps of: contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a Q to C8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of R,R-lactyllactic acid, hydrolysing the aliphatic ester of R,R-lactyllactic acid to produce R-lactic acid or, where the aliphatic ester of lactic acid is an aliphatic ester of R-lactic acid, hydrolysing the aliphatic ester of R-lactic acid to produce R-lactic acid. Preferably, the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid. The R-lactic acid produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
Alternatively, in a fourth further embodiment there is provided a process for producing S,S-lactide characterised by the steps of contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol (e.g. a C\ to C8 alkyl alcohol) and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer, and aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer;
separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of S,S-lactyllactic acid, converting the aliphatic ester of S,S-lactyllactic acid to S,S-lactide or, where the aliphatic ester of lactic acid is an aliphatic ester of S- lactic acid, converting the aliphatic ester of S-lactic acid to S,S-lactide. Preferably, the mixture of R,R- and S,S- lactide used in the process has been prepared from a mixture of R- and S- lactic acid. The S,S-lactide produced by the process preferably has an enantiomeric excess of at least 90%, more preferably at least 95%, still more preferably at least 98%, most preferably at least 99%.
Conversion of the mixture of R- and S- lactic acid into a mixture of R,R and S,S- lactide may result in formation of R,S-lactide, as well as R,R- and S,S-lactide. If desired, R,S- lactide may be separated from R,R- and S,S-lactide by routine methods well known in the art.
Preferably the R,R- and S,S-lactides produced in respectively the second or fourth further embodiments set out above are separately polymerised to produce substantially optically pure PDLA or PLLA. PDLA and PLLA can be combined in varying proportions, for example using melt blending, to produce a range of stereocomplex polylactic acid formulations having an associated range of improved optical and form stability properties relative to either PLLA or PDLA alone. Whilst the relative proportions of these two polymers can vary widely it is preferred that the PLLA content of these formulations lie in the range 40 to 60% based on the total weight of PLLA and PDLA. The stereocomplex polymers so produced can be used in a wide range of applications, including a wider scope of durable uses previously not possible with PLLA.
The invention will now be illustrated by reference to the following examples. Examples 1-3
Stereoselective alcoholysis of rac-lactide in heptane / THF (batch)
A glass reactor was charged with racemic lactide (1 equivalent), n-butanol (1.5 equivalents), Novozym 435 (3% by weight of the racemic lactide) and varying amounts of a 90: 10 (by weight) heptane/THF co-solvent (volumes based on the amount of n-butanol used). The mixture was stirred for 24 hours at room temperature and then analysed by chiral HPLC and NMR spectroscopy for R-n-butyl lactate, S-n-butyl lactate, S,S-n-butyl lactyllactate and R,R n-butyl lactyllactate, so that the composition of the lactate components could be determined. The results are shown in the following table (Nd = not detected):
Figure imgf000016_0001
Examples 4-7
Stereoselective alcoholysis of rac-lactide in butanol (batch)
In a series of experiments 2.89 g of racemic lactide, 100 mg of Novozym 435 (3.5% by weight lactide) and varying quantities of n-butanol (1.5 to 10 equivalents based on the racemic lactide) were mixed together in a glass reactor and stirred for a period of 60 °C for period of up to 24 hours. Samples were removed at varying times and analysed by chiral HPLC and NMR for the presence of R- and S-n-butyl lactate. Using this information % yields of R-n-butyl lactate based on the R,R-component of the racemic lactide starting material were calculated and reported in the following table. In all cases no S-n-butyl lactate was detected and no yields are therefore reported.
Figure imgf000016_0002
Example 8
Distillation to separate butanol, butyl lactate and butyl lactyl lactate 150 g racemic /z-butyl lactyllactate was gently stirred at 50 °C in the presence of 7.5 g Novozym 435 (5 % by weight of substrate) and 195 ml w-butanol for 6 hours, taking the conversion of (R,R)-n-butyl lactyllactate into (R)-n-butyl lactate to in excess of 95%. The immobilised enzyme was then removed by filtration and the bulk of the excess n-butanol removed by rotary evaporation at 50 °C/25 mbar. A portion of the residue (100 ml) was transferred to a round-bottomed flask equipped with a distillation column packed with Raschig rings, a still-head and condenser. Distillation was then carried out at 30 mbar, the vacuum being maintained by a Vacuubrand CVC 2000 controller.
Fractions were collected as summarised in the Table below. Fractions 4 and 5 contained mixtures of (R)-n-butyl lactate and (S,S)-n-butyl lactyllactate, highlighting the difficulty in achieving separation of these components. Fractions 2 and 3 contained (R)-n- butyl lactate but no n-butyl lactylactate. Fraction 3 contained (R)-n-butyl lactate in > 98% ee. The results demonstrate that separation of alkyl lactate from alkyl lactylactate by distillation is possible without significant loss of enantiomeric purity.
Figure imgf000017_0001
Example 9
Analogous experiments to those described in Examples 1 to 7 were carried out using IMMCALB-T2-150, IMMC ALB Y-T2- 150, IMMCALB-Tl-350, or a cross-linked aggregate of lipase B from Candida antarctica, as the enzyme in place of Novozym 435. Those enzymes showed similar levels of stereoselectivity to Novozym 435.
Example 10
Stereoselective alcoholysis of rac-lactide in butanol/acetone mixture (batch)
A glass vessel was charged with rac-lactide (2.30 g), Novozym 435 (115 mg, 5 wt % with respect to lactide), n-butanol (2.9 ml, 2:1 molar ratio with respect to lactide) then acetone (6.8 ml). The mixture was shaken by hand at RT to 45 °C to ensure that the lactide dissolves. Then the vessel was placed in a heated shaker 45°C, 750rpm (t=0). The reaction was monitored over 24 hrs. Samples were analysed by chiral gas chromatography to determine the (5)-butyl lactate, (R)-butyl lactate, (S^-butyl lactyllactate, (R,R)-buty\ lactyllactate, (S, ^-lactide and (i?,i?)-lactide composition. After 24 hrs the reaction reached 89% conversion to (»S)-butyl lactate at an optical purity >99% e.e.
Example 11
Stereoselective alcoholysis of rac-lactide in butanol / acetone mixture with recycle of enzyme (batch) Rac-lactide (1.45 g, 10 mmol) was alcoholised with n-BuOH (2.75 ml, 30 mmol, 3 eq.) and Novozym 435 (200 mg, 14 %) for 7 h at 35 °C in the presence of 2.75 ml of acetone. After 7h the reaction was stopped and analysed for conversion to R-butyl lactate. The reaction liquors were then carefully separated from the immobilised enzyme by syringe and the enzyme was washed with solvent and reused in a subsequent run. The enzyme was reused for 8 repeat runs. Conversion to R-butyl lactate after the 1st run was 92% (of the theoretical yield) and conversion after the 8th run was 79%.
Example 12
Stereoselective alcoholysis of rac-lactide in butanol/acetone mixture with recycle of enzyme (continuous) At regular intervals a 50:50 mixture of (S,S)- and (R,R)- lactide was dissolved in acetone at a concentration of 30% wt lactide in a 1 litre water heated jacketed vessel at 45 °C equipped with a reflux condenser. n-Butanol was then added to the lactide solution so that the n-BuOH/lactide molar ratio was 2:1 at 45 °C; under these conditions the lactide remains in solution. Typical batches were prepared to supply the reaction rig with sufficient substrate to operate for at least 24 h.
The contents were then fed through a 400 mm length reflux column, the exterior collar of which was heated to 45 °C using recirculated heated water. The column was fitted directly onto a glass adaptor containing a 5 g packed bed of Novozym 435 (supported Candida antarctica Lipase B). The solution was fed through the column using a Watson Marlow 120S peristaltic pump and 1.6 mm ID Marprene tubing. Once passed through the enzyme bed the product mixture was collected and samples analysed by gas chromatography. Flow of reactants over the enzyme bed was adjusted to achieve a conversion of (R,R)-butyl lactyllactate into R-butyl lactate in the region 80 - 90%. Even after three months continuous operation conversions were >80% and the optical purity of the R-butyl lactate > 99% e.e.
Example 13
Stereoselective alcoholysis of rac-lactide in butanol/methyl ethyl ketone (MEK) mixture with recycle of enzyme (continuous)
A solution of 10 g rac-lactide, 15 g BuOH, (3 Eq), and 50 g MEK (a ratio of 1 : 1.5 : 5) was passed through a steel column containing 0.500 g Novozym 435 immobilised Candidia antarctica Lipase B over a period of 60 h. Samples for analysis were taken at 2 hourly intervals from the feed and from the output of the column and the concentrations of (5)-butyl lactate, (i?)-butyl lactate, (S^-butyl lactyllactate, (R,i?)-butyl lactyllactate, (S,S)- lactide and (i?, ?)-lactide were determined by chiral liquid chromatography (no S-butyl lactate was detected). The conversion remained steady at 85% and the R-butyl lactate products were all >99% enantiomeric excess. Example 14
Distillation of acetone and butanol from butyl lactate and butyl lactyllactate
A 1 litre 3-necked glass flask was fitted with a magnetic stirrer bar and an insulated 20-plate Oldershaw column surmounted by a Perkin vacuum still head with 250 ml receiver. A feed point approximately half-way up the column allowed feedstock to be charged via a peristaltic pump using PharMed® BPT peristaltic tubing. The flask was heated using an oil bath and vacuum was applied via a Teflon diaphragm pump, with a solid C02 cooled trap.
The feedstock for this distillation consisted of acetone (49% wt); (R)-n-butyl lactate (21% wt); butanol (7% wt); (R,R)-n-butyl lactyllactate (3% wt) and (S,S)-n-butyl lactyllactate (19% wt). The remaining components included trace quantities of (S)-n- butyl lactate and both (S,S)- and (R,R)-lactides.
Initially, some extra butanol was added to the feed charged in order to establish continuous distillation conditions, since the amount of butanol present in the feedstock was low. Once this had been established (oil bath -135 °C, internal temp. ~117 °C, still head temp. ~77 °C, vacuum = 500 mBarA), the main feed was then charged at 2.5 - 5.0 ml/min. Fractions were collected as detailed below and analysed by chiral GC.
Figure imgf000020_0001
From the 702 ml (609.5 g) of feedstock used, the composition of the resulting concentrated product (340.11 g) was: acetone (4.5%); (R)-n-butyl lactate (44.3%); n- butanol (4.7%); (R,R)-n-butyl lactyllactate (5.9%), (S,S)-n-butyl lactyllactate (39.0%) and (S)-n-butyl lactate (0.7%) with the remainder being (S,S)- and (R,R)-lactides.
The composition of the volatile products collected in the cold trap (59.7 g) was: acetone (89%) and butanol (10%) with the remaining 1% being n-butyl lactate.
A continuous distillation set up was constructed comprising a 250 ml Hastelloy reboiler (with sightglass), a trace-heated 20-plate Oldershaw column surmounted by a Perkin vacuum still head with 250 ml receiver. There was a feed point approximately half-way up the column allowing feedstock to be charged via a peristaltic pump using PharMed® BPT peristaltic tubing. The temperature of the reboiler and column heat tracing were electrically controlled. Vacuum was applied via a Teflon diaphragm pump, with a solid C02 cooled trap.
The feedstock for this distillation (1050.0 g) consisted of: acetone (49% wt); (R)- n-butyl lactate (21% wt); butanol (7% wt); (R,R)-n-butyl lactyllactate (3% wt) and (S,S)- n-butyl lactyllactate (19% wt) with traces of (S)-n-butyl lactate and both (S,S)- and (R,R)- lactides.
After the initial filling and conditioning of the column, the feedstock was fed in and rates and temperatures adjusted until steady continuous distillation was achieved. The optimum conditions were found to be vacuum = 100 mBarA; Reboiler temperature = 100 °C; Heat tracing = 65 °C; Feed rate = 4 ml/min.
These conditions were maintained throughout this distillation, and resulted in the product distribution detailed below. This procedure successfully concentrated the higher- boiling components (mainly (R)-n-butyl lactate and (S,S)-n-butyl lactyllactate) in the reboiler in high yields. Acetone and butanol recovery is also high and these solvents may be recycled to earlier stages of the overall process.
Figure imgf000021_0001
BuLa = butyl lactate; BuLaLa = butyl lactyl lactate
Example 15
Distillation of butyl lactate from butyl lactyllactate A continuous distillation apparatus was constructed comprising a 250 ml Hastelloy reboiler with sightglass fitted with a heated 20-plate Oldershaw column surmounted by a Perkin vacuum still head with 250 ml receiver. There was a feed point approximately half-way up the column allowing feedstock to be charged via a peristaltic pump using PharMed® BPT peristaltic tubing. The temperature of the reboiler and column heat tracing were electrically controlled. Vacuum was applied via a Teflon diaphragm pump, with a solid C02 cooled trap.
The feedstock for this distillation (740.5 g) consisted of: acetone (<0.5%); (R)-n- butyl lactate (46%); butanol (3%); (R,R)-n-butyl lactyllactate (6%) and (S,S)-n-butyl lactyllactate (44%) with trace quantities (<0.5%) of (S)-n-butyl lactate and both (S,S)- and (R,R)-lactides.
After the initial filling and conditioning of the column, the feedstock was fed in and rates and temperatures adjusted until steady continuous distillation was achieved. The optimum conditions were found to be: Vacuum = 35 mBarA; reboiler temperature = 150 °C; Heat tracing = 110 °C; Feed rate = 1 - 4 ml/min. These conditions were maintained throughout this distillation, and resulted in the product distribution detailed below:
Figure imgf000022_0001
BuLa = butyl lactate; BuLaLa = butyl lactyl lactate
The distilled product analysed as 93.9% (R)-butyl lactate; 0.4% (S)-butyl lactate, 5.0% butanol; 0.5% (S,S)-butyl lactyllactate; 0.1% (R,R)-butyl lactyllactate and 0.1% (R,R)- lactide.

Claims

CLAIMS:
1. A process for treating a mixture of R,R- and S,S- lactide characterised by the steps of:
(a) contacting the mixture of R,R- and S,S- lactide with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer;
(b) separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; and
(c) separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation.
2. A process as claimed in claim 1 characterised in that a solvent which is miscible with the aliphatic alcohol is employed in step (a).
3. A process as claimed in claim 1 or claim 2, wherein aliphatic ester of lactic acid is separated from aliphatic ester of lactyllactic acid by fractional distillation at a pressure of from 1 ,000 Pa to 5,000 Pa and at a temperature of from 50°C to 120°C.
4. A process as claimed in any one of the preceding claims characterised in that the aliphatic ester of lactic acid separated by fractional distillation has an enantiomeric excess of at least 90%.
5. A process as claimed in any one of the preceding claims characterised in that the aliphatic ester of lactyllactic acid separated by fractional distillation has an enantiomeric excess of at least 90%.
6. A process as claimed in any one of the preceding claims characterised in that a C2 to C8 aliphatic alcohol is used in step (a), preferably n-butanol.
7. A process as claimed in claim 6 characterised in that the molar ratio of C2 to C8 aliphatic alcohol to racemic lactide is in the range 2:1 to 5:1, preferably 2:1 to 3:1.
8. A process as claimed in any one of the preceding claims characterised in that the enzyme is a Candida antarctica lipase B, and the aliphatic ester of lactic acid and the aliphatic ester of lactyllactic acid are respectively an aliphatic ester of R-lactic acid and an aliphatic ester of S,S- lactyllactic acid.
9. A process as claimed in any one of the preceding claims characterised in that the enzyme is chemically or physically immobilised on a porous support.
10. A process as claimed in any one of the preceding claims characterised by the further step of converting one or both of the aliphatic ester of lactyllactic acid and the aliphatic ester of lactic acid into the corresponding R,R- or S,S- enantiomer of lactide and/or the corresponding R- or S- enantiomer of lactic acid.
11. A process as claimed in any one of the preceding claims characterised in that the mixture of R,R- and S,S- lactide used in step (a) has been prepared from a mixture of R- and S- lactic acid.
12. A process as claimed in claim 11 characterised in that the mixture of R- and S- lactic acid has been prepared by treating a monosaccharide or glycerol with a base.
13. A process for producing S-lactic acid characterised by the steps of: contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of S,S-lactyllactic acid, hydrolysing the aliphatic ester of S,S- lactyllactic acid to produce S- lactic acid or, where the aliphatic ester of lactic acid is an aliphatic ester of S-lactic acid, hydrolysing the aliphatic ester of S-lactic acid to produce S-lactic acid.
14. A process as claimed in claim 13 characterised in that the mixture of R,R- and S,S- lactide has been prepared from a mixture of R- and S- lactic acid.
15. A process as claimed in claim 13 or claim 14 characterised in that the S-lactic acid produced by the process has an enantiomeric excess of at least 90%.
16. A process for producing R-lactic acid characterised by the steps of: contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of R,R-lactyllactic acid, hydrolysing the aliphatic ester of R,R- lactyllactic acid to produce R- lactic acid or, where the aliphatic ester of lactic acid is an aliphatic ester of R-lactic acid, hydrolysing the aliphatic ester of R-lactic acid to produce R-lactic acid.
17. A process as claimed in claim 16 characterised in that the mixture of R,R- and S,S- lactide has been prepared from a mixture of R- and S- lactic acid.
18. A process as claimed in claim 16 or claim 17 characterised in that the R-lactic acid produced by the process has an enantiomeric excess of at least 90%.
19. A process for producing R,R-lactide characterised by the steps of contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of R,R-lactyllactic acid, converting the aliphatic ester of R,R-lactyllactic acid to R,R-lactide or, where the aliphatic ester of lactic acid is an aliphatic ester of R- lactic acid, converting the aliphatic ester of R-lactic acid to R,R-lactide.
20. A process as claimed in claim 19 characterised in that the mixture of R,R- and S,S- lactide has been prepared from a mixture of R- and S- lactic acid.
21. A process as claimed in claim 19 or claim 20 characterised in that the R,R-lactide produced by the process has an enantiomeric excess of at least 90%.
22. A process for producing S,S-lactide characterised by the steps of contacting a mixture of R,R- and S,S- lactide with an aliphatic alcohol and an enzyme to produce a mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer; separating the mixture comprising aliphatic ester of lactic acid corresponding to one lactide enantiomer and the aliphatic ester of lactyllactic acid corresponding to the other lactide enantiomer from the enzyme, and recycling the enzyme to the process; separating the aliphatic ester of lactic acid from the aliphatic ester of lactyllactic acid by fractional distillation; and either, where the aliphatic ester of lactyllactic acid is an aliphatic ester of S,S-lactyllactic acid, converting the aliphatic ester of S,S-lactyllactic acid to S,S-lactide or, where the aliphatic ester of lactic acid is an aliphatic ester of S- lactic acid, converting the aliphatic ester of S-lactic acid to S,S-lactide.
23. A process as claimed in claim 22 characterised in that the mixture of R,R- and S,S- lactide has been prepared from a mixture of R- and S- lactic acid.
24. A process as claimed in claim 22 or claim 23 characterised in that the S,S-lactide produced by the process has an enantiomeric excess of at least 90%.
25. A process as claimed in any one of claims 13 to 24, wherein aliphatic ester of lactic acid is separated from aliphatic ester of lactyllactic acid by fractional distillation at a pressure of from 1,000 Pa to 5,000 Pa and at a temperature of from 50 °C to 120 °C.
26. A process as claimed in any one of claims 19 to 25 characterised in that the R,R- lactide and/or S,S-lactide so produced is polymerised to produce poly-S-lactic acid and/or poly-R-lactic acid respectively.
27. A process as claimed in claim 26 characterised in that the poly-S-lactic acid and/or poly-R-lactic acid so produced is melt blended to form stereocomplex polylactic acid.
PCT/GB2012/051698 2011-07-15 2012-07-16 Separation process WO2013011298A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US14/232,365 US9045782B2 (en) 2011-07-15 2012-07-16 Process for the production of optically-active esters of lactic acid and lactyllactic acid
CN201280034985.9A CN103649324B (en) 2011-07-15 2012-07-16 Separation method
NZ619163A NZ619163B2 (en) 2011-07-15 2012-07-16 Separation process
JP2014519638A JP2014522652A (en) 2011-07-15 2012-07-16 Separation method
AU2012285565A AU2012285565B2 (en) 2011-07-15 2012-07-16 Separation process
CA2841930A CA2841930A1 (en) 2011-07-15 2012-07-16 Separation process
EP12740196.6A EP2732042A1 (en) 2011-07-15 2012-07-16 Separation process
BR112014000848-5A BR112014000848B1 (en) 2011-07-15 2012-07-16 production process of an aliphatic ester of lactic acid and an aliphatic ester of lactyl-lactic acid
KR1020147001960A KR20140077877A (en) 2011-07-15 2012-07-16 Separation process
ZA2013/09691A ZA201309691B (en) 2011-07-15 2013-12-20 Separation process

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB201112296A GB201112296D0 (en) 2011-07-15 2011-07-15 Separation process
GB201112297A GB201112297D0 (en) 2011-07-15 2011-07-15 Separation process
GB1112297.5 2011-07-15
GB1112296.7 2011-07-15
GB201210275A GB201210275D0 (en) 2012-06-11 2012-06-11 Lactate production process
GB1210275.2 2012-06-11

Publications (1)

Publication Number Publication Date
WO2013011298A1 true WO2013011298A1 (en) 2013-01-24

Family

ID=46582015

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/GB2012/051695 WO2013011295A1 (en) 2011-07-15 2012-07-16 Separation process
PCT/GB2012/051698 WO2013011298A1 (en) 2011-07-15 2012-07-16 Separation process
PCT/GB2012/051696 WO2013011296A2 (en) 2011-07-15 2012-07-16 Separation process

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/GB2012/051695 WO2013011295A1 (en) 2011-07-15 2012-07-16 Separation process

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/GB2012/051696 WO2013011296A2 (en) 2011-07-15 2012-07-16 Separation process

Country Status (11)

Country Link
US (3) US9045783B2 (en)
EP (3) EP2732043A2 (en)
JP (3) JP6340496B2 (en)
KR (2) KR20140053129A (en)
CN (3) CN103649323B (en)
AU (2) AU2012285565B2 (en)
BR (3) BR112014000848B1 (en)
CA (2) CA2841930A1 (en)
ES (1) ES2684506T3 (en)
WO (3) WO2013011295A1 (en)
ZA (3) ZA201309691B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015001330A1 (en) * 2013-07-01 2015-01-08 Plaxica Limited Lactate production process
WO2015092425A1 (en) 2013-12-20 2015-06-25 Krew Environmental Limited Manufacture of lactic acid

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014000848B1 (en) * 2011-07-15 2021-03-09 Plaxica Limited production process of an aliphatic ester of lactic acid and an aliphatic ester of lactyl-lactic acid
CN111118073B (en) * 2019-12-27 2022-02-15 宜昌东阳光生化制药有限公司 Method for synthesizing intermediate of ezetimivir by enzyme method
JP2024504157A (en) * 2021-06-10 2024-01-30 エルジー・ケム・リミテッド Isolation method of lactide racemate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2371281A (en) * 1945-03-13 Lactyuactic esters and process of
US7829740B2 (en) 2005-06-29 2010-11-09 Heiji Enomoto Process for production of lactic acid and equipment for the production
GB2484674A (en) 2010-10-18 2012-04-25 Plaxica Ltd Process for producing a lactic acid-amine complex

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2610196A (en) * 1950-03-27 1952-09-09 Charles H Fisher Esters of acylated hydroxycarboxylic acids
US4835293A (en) * 1987-02-24 1989-05-30 E. I. Du Pont De Nemours And Company Atmospheric pressure process for preparing pure cyclic esters
US5274127A (en) * 1990-09-18 1993-12-28 Biopak Technology, Ltd. Lactide production from dehydration of aqueous lactic acid feed
US6005067A (en) 1992-01-24 1999-12-21 Cargill Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
JP3502419B2 (en) * 1993-03-02 2004-03-02 株式会社武蔵野化学研究所 Method for producing lactic acid and lactic acid ester
JPH07165753A (en) 1993-12-08 1995-06-27 Musashino Kagaku Kenkyusho:Kk Purification of lactide
JP2560259B2 (en) * 1994-10-21 1996-12-04 工業技術院長 Method for producing lactide
JP2002030523A (en) * 2000-07-14 2002-01-31 Toray Ind Inc Polylactic acid fiber
US20050009158A1 (en) 2003-03-07 2005-01-13 Arindam Roy Process for enzymatically resolving an enantiomeric mixture of alpha-hydroxy acids
KR100622280B1 (en) 2004-04-27 2006-09-18 한국화학연구원 Process for preparation of alkyl s-l-lactate and alkyl r-d-o-acyllactate using lipase
KR100592794B1 (en) 2005-01-06 2006-06-28 한국화학연구원 Method for preparation of alkyl lactate from lactide using lipase
CA2656697C (en) * 2006-07-06 2012-12-04 Stepan Company Alkyl lactyllactates and processes of making the same
JP2008206402A (en) * 2007-02-23 2008-09-11 Ccy:Kk Method for producing lactic acid ester
JP2009144258A (en) * 2007-12-11 2009-07-02 Teijin Fibers Ltd Direct drawn polylactic acid fiber and method for producing the same
JP2009142217A (en) * 2007-12-14 2009-07-02 Tohoku Biomass Giken:Kk Synthesis method of lactate by enzyme
JP5169294B2 (en) * 2008-02-20 2013-03-27 ダイソー株式会社 Method for optical resolution of lactate ester
KR101012483B1 (en) 2008-07-08 2011-02-09 김용환 Method for Synthesis of Chirally Pure Lactide and Separation of Chirally Pure Lactic Acid or Alkyl Lactate through Enzymatic Transformation
EP2321294B1 (en) 2008-08-29 2015-09-30 Uhde Inventa-Fischer GmbH Process for preparing a mixture of lactide derivatives
JP5748674B2 (en) 2009-03-13 2015-07-15 ネーチャーワークス エルエルシー Recovery of lactic acid equivalents from meso lactide streams
KR101154029B1 (en) * 2009-05-20 2012-06-07 한국화학연구원 Catalyst for direct conversion of esters of lactic acid to lactide and the method for producing the lactide using the same
BR112014000848B1 (en) * 2011-07-15 2021-03-09 Plaxica Limited production process of an aliphatic ester of lactic acid and an aliphatic ester of lactyl-lactic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2371281A (en) * 1945-03-13 Lactyuactic esters and process of
US7829740B2 (en) 2005-06-29 2010-11-09 Heiji Enomoto Process for production of lactic acid and equipment for the production
GB2484674A (en) 2010-10-18 2012-04-25 Plaxica Ltd Process for producing a lactic acid-amine complex

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
FINDRIK ET AL: "Evaluation of factors influencing the enantioselective enzymatic esterification of lactic acid in ionic liquid", BIOPROCESS AND BIOSYSTEMS ENGINEERING, vol. 35, 22 October 2011 (2011-10-22), pages 625 - 635, XP035044355 *
JEON ET AL., TETRAHEDRON LETTERS, vol. 47, 2006, pages 6517 - 6520
JEON ET AL: "Synthesis of alkyl (R)-lactates and alkyl (S,S)-O-lactyllactates by alcoholysis of rac-lactide using Novozym 435", TETRAHEDRON LETTERS, vol. 47, 2006, pages 6517 - 6520, XP025004806 *
NISHIDA ET AL., POLYMER DEGRADATION AND STABILITY, vol. 92, 2007, pages 552 - 559
NUMATA ET AL: "Branched poly(lactide) synthesized by enzymatic polymerization: Effects of molecular branches and stereochemistry on enzymatic degradation and alkaline hydrolysis", BIOMACROMOLECULES, vol. 8, 2007, pages 3115 - 3125, XP002682739 *
SHUKLOV ET AL., TETRAHEDRON LETTERS, vol. 52, 2011, pages 1027 - 30
SHUKLOV ET AL: "Studies on the epimerization of diastereomeric lactides", TETRAHEDRON LETTERS, vol. 52, 30 December 2010 (2010-12-30), pages 1027 - 1030, XP028129681 *
TAKWA ET AL: "Rational redesign of Candida antarctica lipase B for the ring opening polymerization of D,D-lactide", CHEMICAL COMMUNICATIONS, vol. 47, 23 May 2011 (2011-05-23), pages 7392 - 7394, XP002682740 *
TAKWA: "Lipase specificity and selectivity", DOCTORAL THESIS, September 2010 (2010-09-01), Royal Institute of Technology, School of Biotechnology, Stockholm, Sweden, XP002682741, Retrieved from the Internet <URL:http://kth.diva-portal.org/smash/record.jsf?pid=diva2:355255> [retrieved on 20120903] *
YANG ET AL: "Improved preparation of D,L-lactide from D,L-lactic acid using microwave irradiation", POLYMER BULLETIN, vol. 61, 2008, pages 177 - 188, XP019625851 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015001330A1 (en) * 2013-07-01 2015-01-08 Plaxica Limited Lactate production process
WO2015092425A1 (en) 2013-12-20 2015-06-25 Krew Environmental Limited Manufacture of lactic acid

Also Published As

Publication number Publication date
AU2012285562B2 (en) 2015-09-17
ZA201309692B (en) 2014-08-27
US20140141475A1 (en) 2014-05-22
WO2013011296A3 (en) 2013-07-25
US20140342413A1 (en) 2014-11-20
JP6340496B2 (en) 2018-06-13
US9045781B2 (en) 2015-06-02
WO2013011296A2 (en) 2013-01-24
EP2732043A2 (en) 2014-05-21
BR112014000901B1 (en) 2021-02-02
ZA201400119B (en) 2015-06-24
KR20140077877A (en) 2014-06-24
EP2732041A1 (en) 2014-05-21
EP2732041B1 (en) 2018-04-11
BR112014000885A2 (en) 2017-02-21
CA2841930A1 (en) 2013-01-24
JP2014522652A (en) 2014-09-08
US9045783B2 (en) 2015-06-02
NZ619106A (en) 2015-08-28
BR112014000885B1 (en) 2020-12-01
BR112014000848A2 (en) 2017-02-21
CN103649323A (en) 2014-03-19
CA2841929A1 (en) 2013-01-24
US9045782B2 (en) 2015-06-02
NZ619163A (en) 2015-08-28
CN103649323B (en) 2016-05-25
AU2012285565B2 (en) 2015-09-17
CN103687955B (en) 2016-05-11
BR112014000901A2 (en) 2017-02-21
WO2013011295A1 (en) 2013-01-24
ES2684506T3 (en) 2018-10-03
CN103649324A (en) 2014-03-19
AU2012285562A1 (en) 2014-01-16
BR112014000848B1 (en) 2021-03-09
EP2732042A1 (en) 2014-05-21
CN103649324B (en) 2016-05-25
JP2014522651A (en) 2014-09-08
AU2012285565A1 (en) 2014-01-16
CN103687955A (en) 2014-03-26
JP2014521601A (en) 2014-08-28
US20140147898A1 (en) 2014-05-29
ZA201309691B (en) 2014-08-27
KR20140053129A (en) 2014-05-07

Similar Documents

Publication Publication Date Title
US20180155747A1 (en) Lactate Production Process
US9045782B2 (en) Process for the production of optically-active esters of lactic acid and lactyllactic acid
NZ619163B2 (en) Separation process
WO2014045036A1 (en) Lactate production process
NZ619106B2 (en) Separation process
WO2015001330A1 (en) Lactate production process
JP2008545439A (en) Method for producing macrocyclic polyester oligomer by enzyme catalyst
JP2006524989A (en) Continuous bioreactor process for producing polyester cyclic oligomers
JP2006014636A (en) Method for producing acyl derivative

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12740196

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2841930

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 14232365

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2014519638

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2012285565

Country of ref document: AU

Date of ref document: 20120716

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2012740196

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012740196

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20147001960

Country of ref document: KR

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112014000848

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112014000848

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20140114